Pharmaco-Toxicological Mode of Action of Antimicrobial 5-Nitroimidazole Derivatives

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 46, Issue 9, 1999, Pages 517-522

  Schmid, A ^a   Schmid, H ^b  

^a NONE   (Germany)

^b NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

ANTIINFECTIVE AGENT; NITROIMIDAZOLE DERIVATIVE;

ANIMAL; MICROBIOLOGICAL EXAMINATION; REVIEW;

ANIMALS; ANTI-INFECTIVE AGENTS; MICROBIAL SENSITIVITY TESTS; NITROIMIDAZOLES;

EID: 0042632836     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0442.1999.00245.x     Document Type: Article

References (27)

1. Acros, J. C., 1978: Criteria for selecting chemical compounds for carcinogenicity resting: An essay. J. Environ. Path. Toxicol. 1, 433-458.
2. Adams, G. E., I. J. Stratford, J. C. M. Bremner, S. Cole, H. S. Edwards, and E. M. Fielden, 1991: Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs. Radiother. Oncol. Suppl. 20, 85-91.
3. Assandri, A., A. Perazzi, L. F. Zerilli, P. Ferrari, and E. Martinelli, 1978: Metabolism of 5-isopropyl-1-methyl-2-nitro-1H-imidazole. Identification of some urinary metabolites in the dog. Drug Metabol. Dispos. 6, 109-113.
4. Flockhart, I. R., P. Large, D. Troup, S. L. Malcolm, and T. R. Marten, 1978: Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole. Xenobiotica 8, 97-105.
5. Frey, H. H., and W. Löscher, Hrsg., 1996: Lehrbuch der Pharmakologie und Toxikologie für die Veterinärmedizin, (pp. 502-503). Enke, Stuttgart.
6. Gringauz, A., 1997: Introduction to Medicinal Chemistry. How Drugs Act and Why, (p. 275). Wiley-VCH, New York and Weinheim.
7. Hewick, D. S., 1982: Reductive metabolism of nitrogen-containing functional groups. In: Jakoby, W. B., J. R. Bend, and J. Caldwell (eds), Metabolic Basis of Detoxication, (pp. 151-170). Academic Press, New York.
8. Johnson, P. J., 1993: Metronidazole and drug resistance. Parasitol. Today 9, 183-186.
9. Koch, R. L., E. J. T. Chrystal, B. B. Beaulieu, and P. Goldman, 1979: Acetamide, a metabolite of metronidazole formed by the intestinal flora. Biochem. Pharmacol. 28, 3611-3615.
10. Miwa, G. T., S. B. West, J. S. Walsh, F. J. Wolf, and A. Y. H. Lu, 1982: Drug residue formation from ronidazole, a 5-nitroimidazole. III. Studies on the mechanism of protein alkylation in vitro. Chem.-Biol. Interact. 41, 297-312.
11. Mutschler, E., and M. Schäfer-Korting, Hrsg., 1996: Arzneimittelwirkungen, 7te Aufl., (pp. 692-694). Wiss. Verlagsgesellschaft, Stuttgart.
12. Negwer, M., 1987: Organic-chemical Drugs and Their Synonyms, 6th edn. Akademie-Verlag, Berlin.
13. Parkinson, A., 1996: Biotransformation of xenobiotics. In: Klaassen, C. D., M. O. Amdur, and J. Doull (eds), Casarett and Doull's Toxicology, 5th edn, (p. 120). McGraw-Hill, New York.
14. Perez-Reyes, E., B. Kalyanaraman, and R. P. Mason, 1980: The reductive metabolism of metronidazole and ronidazole by aerobic liver microsomes. Molecular Pharmacol. 17, 239-244.
15. Rosenblum, Ch., N. R. Trenner, R. P. Buhs, Ch. B. Hiremath, F. R. Koniuszy, and D. E. Wolf, 1972: Metabolism of ronidazole (1-methyl-5-nitroimidazol-2-ylmethyl carbamate). J. Agric. Food Chem. 20, 360-371.
16. Rozenski, J., C. J. De Ranter, and H. Verplanken, 1995: Quantitative structure-activity relationships for antimicrobial nitroheterocyclic drugs. Quant. Struct.-Act. Relat. 14, 134-141.
17. Rustia, M., and P. Shubik, 1972: Induction of lung tumors and malignant lymphomas in mice by metronidazole. J. Natl. Cancer Inst. 48, 721-729.
18. Rustia, M., and P. Shubik, 1979: Experimental induction of hepatomas, mammary tumors, and other tumors with metronidazole in noninbred Sas:MRC (W1) BR rats. J. Natl. Cancer Inst. 63, 863-868.
19. Schmid, A., 1985: Toxikologische Beurteilung von Nitrofuranderivaten. Tierärztl. Praxis. 13, 471-477.
20. Scott, Th., and E. I. Mercer, 1997: Concise Encyclopedia Biochemistry and Molecular Biology, 3rd edn. de Gruyter, Berlin.
21. Voogd, C. E., 1981: On the mutagenicity of nitroimidazoles. Mutat. Res. 86, 243-277.
22. Weiss, G., N. Rose, P. Duke, and T. H. Williams, 1981: A major rat faecal metabolite of ipronidazole. Xenobiotica 11, 207-215.
23. West, S. B., P. G. Wislocki, K. M. Fiorentini, R. Alvaro, F. J. Wolf, and A. Y. H. Lu, 1982a: Drug residue formation from ronidazole, a 5-nitroimidazole. I. Characterization of in vitro protein alkylation. Chem.-Biol. Interact. 41, 265-279.
24. West, S. B., P. G. Wislocki, F. J. Wolf, and A. Y. H. Lu, 1982b: Drug residue formation from ronidazole, a 5-nitroimidazole. II. Involvement of microsomal NADPH-cytochrome P-450 reductase in protein alkylation in vitro. Chem.-Biol. Interact. 41, 281-296.
25. Wolf, F. J., F. P. Baylis, G. E. Smith, Ch. Rosenblum, H. T. Meriwether, R. F. Alvaro, D. E. Wolf, F. R. Koniuszy, and Th. A. Jacob, 1983: Disposition of ronidazole by swine. 1. Radiocarbon content of tissues. J. Agric. Food Chem. 31, 559-564.
26. Wolf, F. J., R. Alvaro, L. R. Chapin, M. L. Green, D. E. Wolf, F. R. Koniuszy, J. J. Steffens, and Th. A. Jacob, 1984a: Tissue residue studies with ronidazole: effect of label site on total radioactivity content of rat tissues. J. Agric. Food Chem. 32, 706-711.
27. Wolf, F. J., R. Alvaro, J. J. Steffens, D. E. Wolf, F. R. Koniuszy, M. L. Green, and Th. A. Jacob, 1984b: Tissue residues due to ronidazole: bioavailability of residues in swine muscle on ingestion by the rat. J. Agric. Food Chem. 32, 711-714.